NEW YORK, Oct. 22, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Retrophin, Inc. ("Retrophin" or the "Company") (NASDAQ: RTRX), concerning whether the board has breached its fiduciary duties to shareholders.
A lawsuit was recently filed against the Company and certain of its executive officers in the U.S. District Court for the Southern District of New York, No. 1:14-cv-07640. The complaint alleges that the Company concealed facts including that its' CEO made illegal stock trades and received grants of shares in violation of the Company's incentive compensation plan.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Retrophin shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Matthew M. Houston, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP